Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) Other Operating Expenses (2016 - 2025)

Neuroone Medical Technologies (NMTC) has disclosed Other Operating Expenses for 9 consecutive years, with $431239.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Operating Expenses rose 10.83% year-over-year to $431239.0, compared with a TTM value of $42151.0 through Dec 2025, down 89.17%, and an annual FY2017 reading of -$3.1 million, changed N/A over the prior year.
  • Other Operating Expenses was $431239.0 for Q4 2025 at Neuroone Medical Technologies, up from -$389088.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $3.1 million in Q2 2021 and bottomed at -$924713.0 in Q3 2021.
  • Average Other Operating Expenses over 3 years is $617651.2, with a median of $410163.5 recorded in 2024.
  • Peak annual rise in Other Operating Expenses hit 10.83% in 2025, while the deepest fall reached 10.83% in 2025.
  • Year by year, Other Operating Expenses stood at -$924713.0 in 2021, then soared by 142.08% to $389088.0 in 2024, then grew by 10.83% to $431239.0 in 2025.
  • Business Quant data shows Other Operating Expenses for NMTC at $431239.0 in Q4 2025, -$389088.0 in Q3 2025, and $389088.0 in Q4 2024.